Literature DB >> 6627703

Effect of treatment of Cushing's syndrome on skeletal muscle structure and function.

A A Khaleeli, D J Betteridge, R H Edwards, J M Round, E J Ross.   

Abstract

The time course of recovery in the myopathy of Cushing's syndrome was studied before and after removal of a pituitary adenoma at hypophysectomy in three patients and an adrenal adenoma in another. Serial measurements were performed of quadriceps force, total muscle mass/body weight, individual fibre size on needle biopsies of the lateral muscle mass of the thigh and skeletal muscle cross-sectional area (CSA) and force/unit CSA on computed (CT) scans of thighs and calves. All patients were weak, and recovery was slow but substantial except in one patient who had persistent Cushing's syndrome. An accompanying increase in overall and type II mean fibre area (MFA) occurred after surgery in the patients with a pituitary adenoma, as did an increase in skeletal muscle CSA and force/unit CSA in both patients having CT scans. The only patient with pronounced muscle wasting showed severe type II fibre atrophy with a reduced total muscle mass/body weight, but muscle morphology and total muscle mass were normal in the other patients. Only in this patient was a significant increase in total muscle mass/body weight noted after surgery. These findings suggest that the increase in muscle mass which may follow hypophysectomy in Cushing's syndrome is due to an increase in individual cell size.

Entities:  

Mesh:

Year:  1983        PMID: 6627703     DOI: 10.1111/j.1365-2265.1983.tb00030.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  Diagnostic work-up in steroid myopathy.

Authors:  Marco Alessandro Minetto; Valentina D'Angelo; Emanuela Arvat; Santosh Kesari
Journal:  Endocrine       Date:  2017-11-15       Impact factor: 3.633

2.  Severe respiratory failure secondary to Cushing's myopathy.

Authors:  C Blanco; M Marazuela; J Flores; J Alvarez
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

Review 3.  The pituitary-adrenal axis and body composition.

Authors:  Eva Fernandez-Rodriguez; Paul M Stewart; Mark S Cooper
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 4.  Glucocorticoid excess and COVID-19 disease.

Authors:  Valentina Guarnotta; Rosario Ferrigno; Marianna Martino; Mattia Barbot; Andrea M Isidori; Carla Scaroni; Angelo Ferrante; Giorgio Arnaldi; Rosario Pivonello; Carla Giordano
Journal:  Rev Endocr Metab Disord       Date:  2020-10-06       Impact factor: 6.514

5.  Reversible alterations in cardiac morphology and functions in a patient with Cushing's syndrome.

Authors:  Hiroaki Iwasaki
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2014-06-01

6.  Blocking extracellular activation of myostatin as a strategy for treating muscle wasting.

Authors:  M Pirruccello-Straub; J Jackson; S Wawersik; M T Webster; L Salta; K Long; W McConaughy; A Capili; C Boston; G J Carven; N K Mahanthappa; K J Turner; A Donovan
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

Review 7.  MRI and muscle imaging for idiopathic inflammatory myopathies.

Authors:  Samuel Malartre; Damien Bachasson; Guillaume Mercy; Elissone Sarkis; Céline Anquetil; Olivier Benveniste; Yves Allenbach
Journal:  Brain Pathol       Date:  2021-05       Impact factor: 6.508

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.